|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6900 MYR | -0.72% |
|
-0.72% | - |
| Market Cap | 153M 37.43M 32.49M 30.42M 27.83M 52.53M 3.57B 53.22M 356M 140M 1.78B 141M 137M 5.93B | P/E 2026 * |
9.8x | P/E 2027 * | 9.27x |
|---|---|---|---|---|---|
| Enterprise Value | 153M 37.43M 32.49M 30.42M 27.83M 52.53M 3.57B 53.22M 356M 140M 1.78B 141M 137M 5.93B | EV / Sales 2026 * |
0.63x | EV / Sales 2027 * | 0.58x |
| Free-Float |
15.82% | Yield 2026 * |
3.62% | Yield 2027 * | 3.91% |
| 1 day | -0.72% | ||
| 1 week | -0.72% | ||
| Current month | -0.72% | ||
| 6 months | +0.73% |
| 1 week | 0.69 | 0.69 | |
| 1 month | 0.68 | 0.7 | |
| Current year | 0.62 | 0.72 | |
| 1 year | 0.62 | 0.72 | |
| 3 years | 0.58 | 0.8 | |
| 5 years | 0.58 | 0.8 | |
| 10 years | 0.57 | 1.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ban Keong Lim
CEO | Chief Executive Officer | 55 | 2015-03-31 |
Yan San Chan
DFI | Director of Finance/CFO | 56 | 2013-12-31 |
| Chief Operating Officer | 38 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 2015-03-31 | |
Ban Keong Lim
BRD | Director/Board Member | 55 | 2015-03-31 |
Kam Weng Foong
BRD | Director/Board Member | 66 | 2015-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/31/25 | Buy | Chief Executive Officer | 110,000 | 0.0497% | ||
| 9/22/23 | Buy | Chief Executive Officer | 17,000 | 0.0077% | ||
| 9/8/23 | Buy | Chief Executive Officer | 103,000 | 0.0466% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.72% | -0.72% | +8.66% | -1.43% | 37.67M | ||
| +1.66% | +2.87% | +59.19% | +161.66% | 1,043B | ||
| -0.48% | +0.57% | +50.82% | +48.63% | 621B | ||
| -0.90% | -4.98% | +24.60% | +62.70% | 435B | ||
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | ||
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | ||
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | ||
| -0.96% | +4.31% | +42.04% | +59.86% | 220B | ||
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | ||
| -0.74% | -0.24% | +18.76% | +62.35% | 164B | ||
| Average | -0.28% | -3.43% | +29.49% | +43.35% | 358.92B | |
| Weighted average by Cap. | +0.19% | -3.79% | +40.59% | +74.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 244M 59.57M 51.69M 48.4M 44.28M 83.59M 5.67B 84.68M 566M 222M 2.84B 224M 219M 9.44B | 265M 64.88M 56.3M 52.72M 48.22M 91.04M 6.18B 92.23M 617M 242M 3.09B 244M 238M 10.28B |
| Net income | 15.6M 3.81M 3.31M 3.1M 2.84M 5.35M 363M 5.42M 36.26M 14.23M 182M 14.32M 14.01M 604M | 15.6M 3.81M 3.31M 3.1M 2.84M 5.35M 363M 5.42M 36.26M 14.23M 182M 14.32M 14.01M 604M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | MYR 0.6900 | -0.72% | 100 |
| 26-07-28 | MYR 0.6950 | 0.00% | 3,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 5278 Stock
Select your edition
All financial news and data tailored to specific country editions
















